Proteome Sciences (LON:PRM) Trading 34.6% Higher – Here’s Why

Proteome Sciences plc (LON:PRM) shares rose 34.6% during trading on Wednesday . The stock traded as high as GBX 2 and last traded at GBX 1.89. 782,692 shares changed hands during mid-day trading, an increase of 87% from the average session volume of 417,714 shares. The stock had previously closed at GBX 1.40.

Proteome Sciences Stock Up 34.6%

The company has a market capitalization of £6.61 million, a P/E ratio of -1.81 and a beta of 0.15. The company has a 50-day moving average of GBX 1.59 and a two-hundred day moving average of GBX 1.87. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46.

Proteome Sciences (LON:PRM) last announced its earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share for the quarter. The business had revenue of GBX 376 million for the quarter. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.